Division of Medical Toxicology, University of California San Diego, San Diego, California; Department of Emergency Medicine, University of California San Diego, San Diego, California
Auto-generated profile, based on publicly available information
Christie Sun
Division of Medical Toxicology, University of California San Diego, San Diego, California; Department of Emergency Medicine, University of California San Diego, San Diego, California
Using a large consortium of undergraduate students in an organized program at the University of California, Los Angeles (UCLA), we have undertaken a functional genomic screen in the Drosophila eye. In addition to the educational value of discovery-based learning, this article presents the first comprehensive genomewide analysis of essential genes involved in eye development. The data reveal the surprising result that the X chromosome has almost twice the frequency of essential genes involved in eye development as that found on the autosomes.
Background: In January 2012, carisoprodol was classified as a Schedule IV substance under the controlled substances act from a previously non-controlled, non-scheduled classification. Carisoprodol is marketed as a skeletal muscle relaxant and is commonly cited for its abuse potential. Objectives: We aimed to compare volume of calls involving carisoprodol abuse or misuse to a statewide poison control system before and after the scheduling change. Methods: Data were extracted from poison control calls coded as “misuse/abuse” involving carisoprodol from four years before (2008 to 2011) and four years after (2012 to 2015) the scheduling change. The volume of calls from pre- and post-scheduling change was compared after adjusting for yearly California census data. Results: The number of calls related to carisoprodol abuse or misuse was significantly decreased in the four years following the change compared to the four years before. Conclusion: Scheduling of carisoprodol was temporally related to decreased exposures as reported to California Poison Control Centers. Governmental regulation may impact a drug’s potential for abuse.